{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T22:26:59Z","timestamp":1781735219733,"version":"3.54.5"},"reference-count":16,"publisher":"Norwegian Medical Association","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"published-print":{"date-parts":[[2013,1,22]]},"DOI":"10.4045\/tidsskr.12.0053","type":"journal-article","created":{"date-parts":[[2013,1,25]],"date-time":"2013-01-25T02:02:10Z","timestamp":1359079330000},"page":"166-8","source":"Crossref","is-referenced-by-count":1,"title":["Medikamentell forskyvning av menstruasjon"],"prefix":"10.4045","volume":"133","author":[{"given":"Kari Hilde","family":"Juvkam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde Beate","family":"Gudim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"Hicks CW, Rome ES. Menstrual manipulation: options for suppressing the cycle. Cleve Clin J Med 2010; 77: 445\u2009\u2013\u200953. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20601618&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.3949\/ccjm.77a.09128","DOI":"10.3949\/ccjm.77a.09128"},{"key":"ref=2","unstructured":"Edelman A, Gallo MF, Jensen JT et al. Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception. Cochrane Database Syst Rev 2010; nr. 8: CD004695."},{"key":"ref=3","unstructured":"Guyton AC, red. J.E.Halls Textbook of medical physiology. 8. utg. Philadelphia, PA: Saunders, 1991: 906\u2009\u2013\u20098."},{"key":"ref=4","unstructured":"Norsk legemiddelh\u00e5ndbok for helsepersonell. Bergen: Fagbokforlaget, 2010. http:\/\/legemiddelhandboka.no\/ (12.1.2012)."},{"key":"ref=5","unstructured":"Statens legemiddelverk. Preparatomtale (SPC) www.legemiddelverket.no\/preparatomtaler (12.1.2012)."},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Kaser DJ, Missmer SA, Berry KF et al. Use of norethindrone acetate alone for postoperative suppression of endometriosis symptoms. J Pediatr Adolesc Gynecol 2012; 25: 105\u2009\u2013\u20098. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16135576&dopt=Abstract","DOI":"10.1016\/j.jpag.2011.09.013"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Muneyyirci-Delale O, Anopa J, Charles C et al. Medical management of recurrent endometrioma with long-term norethindrone acetate. Int J Womens Health 2012; 4: 149\u2009\u2013\u200954. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22505834&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.2147\/IJWH.S27819","DOI":"10.2147\/IJWH.S27819"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Mansour D. Safer prescribing of therapeutic norethisterone for women at risk of venous thromboembolism. J Fam Plann Reprod Health Care 2012; 38: 148\u2009\u2013\u20099. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22691698&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136\/jfprhc-2012-100345","DOI":"10.1136\/jfprhc-2012-100345"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Black A. Canadian contraception consensus\u2013update on Depot Medroxyprogesterone Acetate (dmpa). J Obstet Gynaecol Can 2006; 28: 305\u2009\u2013\u200913. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16776909&dopt=Abstract","DOI":"10.1016\/S1701-2163(16)32125-9"},{"key":"ref=10","unstructured":"Henzl MR, Polan ML. Avoiding menstruation: a\u00a0review of health and lifestyle issues. J Reprod Med 2004; 49: 162\u2009\u2013\u200974. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15098885&dopt=Abstract"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Coffee AL, Sulak PJ, Kuehl TJ. Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen. Contraception 2007; 75: 444\u2009\u2013\u20099. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17519150&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.contraception.2007.01.014","DOI":"10.1016\/j.contraception.2007.01.014"},{"key":"ref=12","unstructured":"Kvan E, Narum S. P-piller med forlenget syklus \u2013 et fremskritt? Tidsskr Nor L\u00e6geforen 2005; 125: 2202\u2009\u2013\u20093. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16138136&dopt=Abstract"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"Lidegaard \u00d8, L\u00f8kkegaard E, Svendsen AL et al. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ 2009; 339: b2890. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19679613&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136\/bmj.b2890","DOI":"10.1136\/bmj.b2890"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"Sulak PJ, Kuehl TJ, Coffee A et al. Prospective analysis of occurrence and management of breakthrough bleeding during an extended oral contraceptive regimen. Am J Obstet Gynecol 2006; 195: 935\u2009\u2013\u200941. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16647684&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.ajog.2006.02.048","DOI":"10.1016\/j.ajog.2006.02.048"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Miller L, Verhoeven CH, Hout J. Extended regimens of the contraceptive vaginal ring: a randomized trial. Obstet Gynecol 2005; 106: 473\u2009\u2013\u200982. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22154396&dopt=Abstract","DOI":"10.1097\/01.AOG.0000175144.08035.74"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"Stewart FH, Kaunitz AM, Laguardia KD et al. Extended use of transdermal norelgestromin\/ethinyl estradiol: a randomized trial. Obstet Gynecol 2005; 105: 1389\u2009\u2013\u200996. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15932834&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1097\/01.AOG.0000160430.61799.f6","DOI":"10.1097\/01.AOG.0000160430.61799.f6"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:34:20Z","timestamp":1781649260000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2013\/01\/legemidler-i-praksis\/medikamentell-forskyvning-av-menstruasjon"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,22]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,1,22]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.12.0053","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,22]]}}}